Net revenues of $183.1 million and $719.9 million, respectively, for the three months and fiscal year ended December 31, 2025GAAP net income of $24.4 million, or $0.51 per share and $98.1 million, or ...
Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...
Ahead of this week's Opening Ceremony at the Winter Olympics in Milan, the World Anti-Doping Agency has addressed claims originating from a German tabloid that male skiers could be injecting ...
The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...
As part of a global trial called KARDIA-2, researchers injected people with hard-to-treat high blood pressure with a medication called zilebesiran. This is designed to be administered every six months ...
Though lab-made peptides are touted as a cure-all, they are not FDA-regulated and pose serious risks, experts warn Here’s a new trend that sounds unwise: buying unregulated substances from dealers in ...
Net revenues of $183.1 million and $719.9 million, respectively, for the three months and fiscal year ended December 31, 2025GAAP net income of $24.4 million, or $0.51 per share and $98.1 million, or ...
Overview: Filgrastim is used to help prevent infection in people who have low levels of white blood cells (neutropenia). It may also be used before a stem cell transplant to increase the amount of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results